(Q30433530)

21 June 2017

Characterization of the yeast tricalbins: membrane-bound multi-C2-domain proteins that form complexes involved in membrane trafficking (English)

1 reference

21 June 2017

Creutz CE

1

1 reference

PubMed ID

15141306

21 June 2017

Snyder SL

series ordinal

2

1 reference

PubMed ID

15141306

21 June 2017

Schulz TA

series ordinal

3

1 reference

21 June 2017

1 May 2004

1 reference

Cellular and Molecular Life Sciences

21 June 2017

1 reference

21 June 2017

61

1 reference

21 June 2017

10

1 reference

21 June 2017

1208-1220

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-004-4029-8

21 June 2017

0 references

cites work

Coronary microembolization

1 reference

12 December 2020

Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction

1 reference

12 December 2020

Primary angioplasty in a high-volume tertiary center in Turkey: in-hospital clinical outcomes of 1625 patients.

1 reference

12 December 2020

Distal embolization during primary angioplasty: histopathologic features and predictability.

1 reference

12 December 2020

Pulmonary embolism and deep vein thrombosis

1 reference

12 December 2020

Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon

1 reference

12 December 2020

Role of adenosine in hyperemic response of coronary blood flow in microembolization

1 reference

12 December 2020

Quality of myocardial reperfusion according to ischemic time and infarcted territory

1 reference

12 December 2020

A macro and micro view of coronary vascular insult in ischemic heart disease.

1 reference

12 December 2020

Association of thrombotic and fibrinolytic factors with severity of culprit lesion in patients with acute coronary syndromes without ST elevation

1 reference

12 December 2020

Role of thrombotic and fibrinolytic factors in acute coronary syndromes

1 reference

12 December 2020

Predictive value of elevated D-dimer in patients undergoing primary angioplasty for ST elevation myocardial infarction.

1 reference

12 December 2020

D-dimer testing in laboratory practice

1 reference

12 December 2020

Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.

1 reference

12 December 2020

Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction

1 reference

12 December 2020

Quantitative d-dimer levels and the extent of venous thromboembolism in CT angiography and lower limb ultrasonography.

1 reference

12 December 2020

Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention

1 reference

12 December 2020

Time to treatment in primary percutaneous coronary intervention

1 reference

12 December 2020

Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction

1 reference

12 December 2020

Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality.

1 reference

12 December 2020

No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention

1 reference

12 December 2020

Recognition of the importance of embolization in atherosclerotic vascular disease

1 reference

12 December 2020

Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center.

1 reference

12 December 2020

Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade

1 reference

12 December 2020

Myocardial no-reflow in humans

1 reference

12 December 2020

Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

1 reference

12 December 2020

Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.

1 reference

12 December 2020

Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization

1 reference

12 December 2020

The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention

1 reference

12 December 2020

No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy

1 reference

12 December 2020

Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention

1 reference

12 December 2020

10.1007/S00018-004-4029-8

Identifiers

DOI

1 reference

21 June 2017

1 reference

PubMed ID

15141306